These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 1227747

  • 1. [Effect of carbidopa and L-dopa combination on the secretion of growth hormone in normal subjects and in patients with Parkinsonism].
    Nurzia A, Vacca U, Pirro R, Cerone G.
    Clin Ter; 1975 Aug 15; 74(3):265-70. PubMed ID: 1227747
    [No Abstract] [Full Text] [Related]

  • 2. [Carbidopa-levodopa, growth hormone and parkinsonism].
    Marti-Masso JF, Carrera N, Martínez-Lage JM.
    Rev Clin Esp; 1976 Jun 30; 141(6):525-32. PubMed ID: 968087
    [No Abstract] [Full Text] [Related]

  • 3. [Hormonal effects of carbidopa-levodopa in normal patients].
    Marti-Masso JF, Carrera N, Martinez-Lage JM.
    Rev Clin Esp; 1976 Jul 15; 142(1):35-41. PubMed ID: 973012
    [No Abstract] [Full Text] [Related]

  • 4. [Stimulation of growth hormone (STH) in the outpatient clinic using L-Dopa plus carbidopa and physical loading].
    Amendt P, Rohde W.
    Kinderarztl Prax; 1979 Jul 15; 47(7):362-7. PubMed ID: 480794
    [No Abstract] [Full Text] [Related]

  • 5. [Stimulation of the secretion of somatotropin by administration of Nacom (L-dopa and L-carbidopa) in ambulatory patients with retarded growth].
    Schönberger W, Grimm W, Ziegler R, Brodt B.
    Monatsschr Kinderheilkd (1902); 1977 May 15; 125(5):485-7. PubMed ID: 876212
    [No Abstract] [Full Text] [Related]

  • 6. The effect of L-dopa with and without decarboxylase inhibitor on growth hormone secretion in children with short stature.
    Fevang FO, Stoa RF, Thorsen T, Aarskog D.
    Acta Paediatr Scand; 1977 Jan 15; 66(1):81-4. PubMed ID: 831384
    [Abstract] [Full Text] [Related]

  • 7. [HGH secretion after oral application of L-dopa and L-carbidopa (author's transl)].
    Schönberger W, Ziegler R, Brodt B, Grimm W.
    Eur J Pediatr; 1976 Jun 08; 122(3):195-200. PubMed ID: 1278188
    [Abstract] [Full Text] [Related]

  • 8. [Stimulation of growth hormone secretion by the anterior pituitary gland using L-DOPA compared to growth hormone secretion following argine, insulin and sleep].
    Lucke C, Höffken B, Morgner KD.
    Verh Dtsch Ges Inn Med; 1974 Jun 08; 80():1328-30. PubMed ID: 4454413
    [No Abstract] [Full Text] [Related]

  • 9. [Somatosensory evoked potentials in patients with parkinsonism during L-dopa decarboxylase inhibitor treatment].
    Koziel H, Kuran W, Zakrzewska F.
    Neurol Neurochir Pol; 1977 Jun 08; 11(1):73-80. PubMed ID: 840365
    [No Abstract] [Full Text] [Related]

  • 10. [Effect of L-DOPA, phentolamine, aminophylline and propranolol on growth hormone secretion in patients with normal anterior pituitary function and subjects with acromegaly].
    De la Fuente E, Souvatzoglou A, von Werder K.
    Verh Dtsch Ges Inn Med; 1974 Jun 08; 80():1325-8. PubMed ID: 4454412
    [No Abstract] [Full Text] [Related]

  • 11. The effect of low dose carbidopa/levodopa on prolactin and growth hormone concentrations in patients with breast cancer and in benign breast tumours.
    Jones MK, Ramsay ID, Jenner PG.
    Br J Clin Pharmacol; 1978 May 08; 5(5):425-30. PubMed ID: 656281
    [Abstract] [Full Text] [Related]

  • 12. [Attempt at potentiation of the action of L-dopa on the secretion of growth hormone by benserazide, disulfiram and propranolol].
    Rochiccioli P, Enjaume P, Dutau G, Ribot C, Augier D.
    Arch Fr Pediatr; 1976 Jan 08; 33(1):55-66. PubMed ID: 985031
    [Abstract] [Full Text] [Related]

  • 13. Effect of the dopa decarboxylase inhibitor MK-486 on L-dopa-induced inhibition of prolactin secretion: evidence for CNS participation in the L-dopa effects.
    Szabo M, Nakawatase C, Kovathana N, Frohman LA.
    Neuroendocrinology; 1977 Jan 08; 24(1):24-34. PubMed ID: 600362
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of Parkinson's disease with carbidopa, a peripheral decarboxylase inhibitor, and levodopa.
    Fermaglich J.
    Med Ann Dist Columbia; 1974 Dec 08; 43(12):587-91. PubMed ID: 4532167
    [No Abstract] [Full Text] [Related]

  • 15. Paradoxial response to dopaminergic agents in parkinsonism.
    Wiener WJ, Kramer J, Nausieda PA, Klawans HL.
    Arch Neurol; 1978 Jul 08; 35(7):453-5. PubMed ID: 666596
    [Abstract] [Full Text] [Related]

  • 16. Action of phenytoin, ethosuximide and of the carbidopa-L-dopa association in semi-chronic cobalt-induced epilepsy in the rat.
    Scuvee-Moreau J, Lepot M, Brotchi J, Gerebtzoff MA, Dresse A.
    Arch Int Pharmacodyn Ther; 1977 Nov 08; 230(1):92-9. PubMed ID: 603313
    [Abstract] [Full Text] [Related]

  • 17. Acute effects of levodopa plus carbidopa on evoked potentials in Parkinson's disease.
    Cosi V, Romani A, Callieco R, Zerbi F.
    Boll Soc Ital Biol Sper; 1984 Mar 30; 60(3):603-9. PubMed ID: 6712828
    [Abstract] [Full Text] [Related]

  • 18. [Dopaminergic control of the diencephalo-pituitary axis for somatotropin secretion].
    Cavagnini F, Pontiroli AE, Raggi U, Peracchi M, Malinverni A.
    Folia Endocrinol; 1973 Dec 30; 26(6):483-9. PubMed ID: 4801258
    [No Abstract] [Full Text] [Related]

  • 19. L-dopa stimulation at growth hormone release in normal subjects and in patients with Sheehan's syndrome.
    Himathongkam T, Tiyapan A, Rajatanavin R, Pitchayayothin N.
    J Med Assoc Thai; 1981 Jan 30; 64(1):19-25. PubMed ID: 7217816
    [No Abstract] [Full Text] [Related]

  • 20. [Growth hormone secretion induced by L-Dopa and a dopa decarboxylase inhibitor blocked by free fatty acids].
    Casanueva F, Villanueva L, Peñalva A, Barrionuevo JA, Vila T, Cabezas-Cerrato J.
    Rev Clin Esp; 1979 May 15; 153(3):221-4. PubMed ID: 482695
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.